难治性或复发性实体瘤的临床试验
总计10618个结果
-
Cosmo Technologies Ltd招聘中
-
PharmAbcineMerck Sharp & Dohme LLC; Novotech (Australia) Pty Limited尚未招聘
-
Chinese PLA General HospitalUTC Therapeutics Inc.招聘中
-
Taiho Oncology, Inc.终止
-
Eucure (Beijing) Biopharma Co., Ltd招聘中
-
Memorial Sloan Kettering Cancer CenterAstraZeneca招聘中
-
St. Jude Children's Research Hospital招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Bristol-Myers Squibb主动,不招人
-
TakedaTakeda Development Center Americas, Inc.主动,不招人晚期或转移性实体瘤美国, 中国, 克罗地亚, 日本, 拉脱维亚, 波兰, 巴西, 立陶宛, 瑞士
-
Merck KGaA, Darmstadt, Germany完全的
-
Gustave Roussy, Cancer Campus, Grand Paris完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)招聘中难治性 MSI - H 实体瘤 PD-(L) 1 治疗之前 | MSI-H 肿瘤美国
-
Shanghai Miracogen Inc.招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Avistone Biotechnology Co., Ltd.Zhejiang Cancer Hospital; Henan Cancer Hospital; Hunan Cancer Hospital; Peking University Cancer... 和其他合作者招聘中